Ekso Bionics Holdings, Inc. (EKSO)
EBITDA Growth
-2451.16%
Quarterly · Period ending:
EKSO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-2451.16%period ending
Latest reported-2451.16%period ending
EKSO Quarterly EBITDA YoY % (1995.47% → -2451.16%)
Year-over-year change
High-resolution chart · PNG
EKSO ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -2,451.1583% | |
| -143.2495% | |
| -27.1651% | |
| 34.6784% | |
| -16.5553% | |
| 12.8456% | |
| -19.5309% | |
| 46.4008% | |
| 50.1538% | |
| 23.2203% | |
| 13.4407% | |
| 27.882% | |
| -43.5614% | |
| 11.4397% | |
| -5.9325% | |
| -131.0248% | |
| -147.3157% | |
| -23.9909% | |
| 28.9328% | |
| -167.7863% | |
| 90.5038% | |
| -51.7688% | |
| -52.9009% | |
| 718.75% | |
| -326.5757% | |
| 62.5101% | |
| 32.1673% | |
| 104.884% | |
| 63.1286% | |
| 15.4172% | |
| 24.6189% | |
| -11.1262% | |
| -48.7366% | |
| 5.4945% | |
| 1.979% | |
| 7.7741% | |
| 6.0042% | |
| -24.7178% | |
| -13.5259% | |
| -29.2298% | |
| 2.825% | |
| -59.3116% | |
| 19.144% | |
| -32.0489% | |
| -30.491% | |
| 95.2046% | |
| -4,564.5437% | |
| -3,393.4568% | |
| -4,607.3717% | |
| -75,347.8227% | |
| 10.5039% | |
| 9,579.25% | |
| 1,995.4714% |